Progyny Q2 EPS $0.15 Beats $0.10 Estimate, Sales $279.37M Beat $261.91M Estimate
Portfolio Pulse from sunil@benzinga.com
Progyny (NASDAQ:PGNY) reported Q2 earnings of $0.15 per share, beating the analyst consensus estimate of $0.10 by 50%. This is a 66.67% increase from the same period last year. The company also reported quarterly sales of $279.37 million, beating the analyst consensus estimate of $261.91 million by 6.67%. This is a 43.27% increase from the same period last year.
August 04, 2023 | 2:21 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Progyny's Q2 earnings and sales exceeded estimates, indicating strong financial performance. This could positively impact the company's stock price in the short term.
Progyny's Q2 earnings and sales have significantly exceeded analyst estimates, indicating strong financial performance. This positive news is likely to increase investor confidence and could lead to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100